Annual Report

Overview

The report presents Jagsonpal Pharmaceuticals Limited's FY2019-20 standalone performance, with revenue from operations of Rs. 15,856.78 lakhs and profit after tax of Rs. 787.08 lakhs. It records a Rs. 7.85 lakhs CSR provision and states that no sexual-harassment complaints were received during the year. Energy consumption by product category was reported as not feasible to maintain because products have different energy requirements.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2019-2020
Period: 1 April 2019 – 31 March 2020
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services